Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (141-150 of 390) with videos related to

Pageof 39
Sort By:
Archives of Gynecology and Obstetrics|November 11, 2009
Optimal treatment for patients with ectopic pregnancies and a history of fertility-reducing factorsSven Becker, Erich Solomayer, René Hornung, et al.
Breast Cancer Research : BCR|August 12, 2009
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cellsTanja Fehm, Oliver Hoffmann, Bahriye Aktas, et al.
Maturitas|July 17, 2013
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1Jing Zhou, Qi Yu, Rong Chen, et al.
Breast Cancer Research and Treatment|May 28, 2015
Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patientsAndreas D Hartkopf, Florin-Andrei Taran, Christina B Walter, et al.
Anticancer Research|July 24, 2010
Number of hysteroscopies and the time interval between hysteroscopy and surgery: influence on peritoneal cytology in patients with endometrial cancerIngolf Juhasz-Böss, Tanja Fehm, Alexander Nauth, et al.
Breast Cancer Research : BCR|October 30, 2007
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 statusTanja Fehm, Sven Becker, Silke Duerr-Stoerzer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignanciesMalgorzata Banys, Erich-Franz Solomayer, Sven Becker, et al.
Breast Cancer Research and Treatment|October 6, 2011
Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spreadAndreas D Hartkopf, Malgorzata Banys, Natalia Krawczyk, et al.
Scientific Reports|August 22, 2015
Exometabolom analysis of breast cancer cell lines: Metabolic signatureLucas Willmann, Thalia Erbes, Sebastian Halbach, et al.
Archives of Gynecology and Obstetrics|March 8, 2020
Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancerMalgorzata Banys-Paluchowski, Tanja Fehm, Hans Neubauer, et al.
Pageof 39

Showing results (141-150 of 390) with videos related to

Sort By:
Pageof 39
Archives of Gynecology and Obstetrics|November 11, 2009
Optimal treatment for patients with ectopic pregnancies and a history of fertility-reducing factorsSven Becker, Erich Solomayer, René Hornung, et al.
Breast Cancer Research : BCR|August 12, 2009
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cellsTanja Fehm, Oliver Hoffmann, Bahriye Aktas, et al.
Maturitas|July 17, 2013
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1Jing Zhou, Qi Yu, Rong Chen, et al.
Breast Cancer Research and Treatment|May 28, 2015
Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patientsAndreas D Hartkopf, Florin-Andrei Taran, Christina B Walter, et al.
Anticancer Research|July 24, 2010
Number of hysteroscopies and the time interval between hysteroscopy and surgery: influence on peritoneal cytology in patients with endometrial cancerIngolf Juhasz-Böss, Tanja Fehm, Alexander Nauth, et al.
Breast Cancer Research : BCR|October 30, 2007
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 statusTanja Fehm, Sven Becker, Silke Duerr-Stoerzer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignanciesMalgorzata Banys, Erich-Franz Solomayer, Sven Becker, et al.
Breast Cancer Research and Treatment|October 6, 2011
Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spreadAndreas D Hartkopf, Malgorzata Banys, Natalia Krawczyk, et al.
Scientific Reports|August 22, 2015
Exometabolom analysis of breast cancer cell lines: Metabolic signatureLucas Willmann, Thalia Erbes, Sebastian Halbach, et al.
Archives of Gynecology and Obstetrics|March 8, 2020
Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancerMalgorzata Banys-Paluchowski, Tanja Fehm, Hans Neubauer, et al.
Pageof 39